Showing results (341-350 of 380) with videos related to

Sort By:
Pageof 38
JAMA Internal Medicine|August 21, 2023
Late Mortality After COVID-19 Infection Among US Veterans vs Risk-Matched Comparators: A 2-Year Cohort AnalysisTheodore J Iwashyna, Sarah Seelye, Theodore S Berkowitz, et al.
Critical Care Medicine|November 12, 2025
Acute Respiratory Distress Syndrome in Trauma 2007-2019: Comprehensive Patient and Center-Level Retrospective Cohort AnalysisZhi Geng, Allyson M Hynes, Alexis M Moren, et al.
Transfusion|July 29, 2024
Real-time performance improvement optimizes damage control resuscitation best practice adherence: Results of a pilot prospective observational studyDaniela Schmulevich, Zhi Geng, Sarah M Joergensen, et al.
JAMA Network Open|June 4, 2025
An Educational Video Game in Trauma Triage at Nontrauma Centers: A Secondary Analysis of a Randomized Clinical TrialDeepika Mohan, Baruch Fischhoff, Victor Talisa, et al.
Trauma Surgery & Acute Care Open|March 27, 2023
Open versus percutaneous tube thoracostomy with and without thoracic lavage for traumatic hemothorax: a novel randomized controlled simulation trialNathaniel R McLauchlan, Noah M Igra, Lydia T Fisher, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Medicine|November 19, 2022
Consensus elements for observational research on COVID-19-related long-term outcomesAndrew J Admon, Pandora L Wander, Theodore J Iwashyna, et al.
Investigational New Drugs|June 29, 2016
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancerGiorgio Scagliotti, Jin Hyoung Kang, David Smith, et al.
JAMA Network Open|April 10, 2024
Risk of Potentially Preventable Hospitalizations After SARS-CoV-2 InfectionDiana J Govier, Meike Niederhausen, Yumie Takata, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2017
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancerJeffrey R Infante, Amita Patnaik, Claire F Verschraegen, et al.
Pageof 38